Summary
CEM cells were infected with three HIV-1 non syncytium-inducing (NSI) strains obtained from AIDS patients or seropositive individuals. The surviving cells were followed for several months in the persistently infected cultures designated 65870/CEM, 65871/CEM and 3929/CEM, and analyzed for virus expression using light and electron microscopy, immunofluorescence, reverse transcriptase assay, polymerase chain reaction amplification (PCR), nucleic acid hybridization and flow cytometry. The virus isolates induced relatively few syncytia and other cytopathic effects in the corresponding cell lines and the number of cells positive for virus expression never rose above 44%. Distinct peaks of antigen-positive cells were obtained, coincident with high levels of reverse transcriptase activity. The cultures were strongly resistant to superinfection by laboratory strain Lai, with the exception of 65870/CEM which expressed HIV antigens in up to 15% of the cells for a few days. However, cell lysis was minimal in all cases. After long-term cultivation of the three cultures, no antigen-positive cells were detected and no trace of virus expression could be observed. The remaining cells consisted entirely of CD4-negative cells. PCR analyses indicated that cells harboring a provirus were progressively eliminated from the cultures, leaving only virus-free cells. In this system, cells carrying a latent provirus survive for a limited period of time before virus activation induces cell lysis. These results suggest that at least three types of cells exist in the CEM cell line: CD4-positive cells which are rapidly killed by the virus, a second type harboring a latent viral genome after the infection and which grow normally until activation of the resident genome by external or internal signal(s), and a third type which represents rare CD4-negative cells present in the initial CEM population and which are selected for by the NSI isolates. This is the first study documenting specific interactions between NSI strains of HIV-1 and distinct subpopulations of CEM cells grown as a single cell culture.
Similar content being viewed by others
References
Asjö B, Morfeldt-Manson L, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyö EM (1986) Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii: 660–662
Bednarik DP, Folks TM (1992) Mechanisms of HIV-1 latency. AIDS 6: 3–16
Boulerice F, Geleziunas R, Bour S, Li H, D'Addario M, Roulston A, Hiscott J, Wainberg MA (1992) Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type 1. J Virol 66: 1183–1187
Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M (1991) Quiescent T lymphocytes as an inductible virus reservoir in HIV-1 infection. Science 254: 423–427
Butera ST, Folks TM (1992) Application of latent HIV-1 infected cellular models to therapeutic intervention. AIDS Res Hum Retroviruses 8: 991–995
Cann AJ, Churcher MJ, Boyd M, O'Brien W, Zhao J-Q, Zack J, Chen ISY (1992) The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J Virol 66: 305–309
Casareale D, Stevenson M, Sakai K, Volsky DJ (1987) A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV). Virology 156: 40–49
Chapel A, Bensussan A, Vilmer E, Dormont D (1992) Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication. J Virol 66: 3966–3970
Cheng-Mayer C, Seto D, Tateno M, Levy JA (1988) Biologic features of HIV-1 that correlate with virulence in the host. Science 240: 80–82
Cheng-Mayer C, Quiroga M, Tung JW, Dina D, Levy JA (1990) Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol 64: 4390–4398
Cloyd MW, Moore BE (1990) Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. Virology 174: 103–116
Dahl K, Martin K, Miller G (1987) Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus. J Virol 61: 1602–1608
de Jong J-J, de Ronde A, Keulen W, Tersmette M, Goudsmit J (1992) Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol 66: 6777–6780
Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359–362
Fauci AS (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617–622
Federico M, Titti F, Butto S, Orecchia A, Carlini F, Taddeo B, Macchi B, Maggiano N, Verani P, Rossi GB (1989) Biologic and molecular characterization of producer and nonproducer clones from HUT-78 cells infected with a patient HIV isolate. AIDS Res Hum Retroviruses 5: 385–396
Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6–13
Fenyö EM, Albert J, Asjö B (1989) Replicative capacity, cytopathic effect and cell tropism of HIV. AIDS 3 [Suppl 1]: S5-S12
Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, Rabson A, Daugherty D, Gendelman HE, Hoggan MD, Venkatesan S, Martin MA (1986) Biological and biochemical characterization of a cloned Leu-3− cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 164: 280–290
Folks TM, Powell DM, Lightfoote MM, Benn S, Martin MA, Fauci AS (1986) Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science 231: 600–602
Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp 120 molecule. J Virol 66: 3183–3187
Greene WC (1990) Regulation of HIV-1 gene expression. Annu Rev Immunol 8: 453–475
Grimaila RJ, Fuller BA, Rennert PD, Nelson MB, Hammarskjöld M-L, Potts B, Murray M, Putney SD, Gray G (1992) Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol 66: 1875–1883
Hahn BH, Gonda MA, Shaw GM, Popovic M, Hoxie JA, Gallo RC, Wong-Staal F (1985) Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci USA 82: 4813–4817
Hoxie JA, Haggarty BS, Rackowski JL, Pillsbury N, Levy JA (1985) Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Science 229: 1400–1402
Jabbar MA, Nayak DP (1990) Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp 160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J Virol 64: 6297–6304
LaFemina RL, Schneider CL, Robbins HL, Callahan PL, LeGrow K, Roth E, Schleif WA, Emini EA (1992) Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol 66: 7414–7419
Levy JA (1988) Mysteries of HIV: challenges for therapy and prevention. Nature 333: 519–522
Levy JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57: 183–289
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual, 1st edn. Cold Spring Harbor, New York
Martins LP, Chenciner N, Wain-Hobson S (1992) Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence. Virology 191: 837–845
McCune JM (1991) HIV-1: the infective process in vivo. Cell 64: 351–363
Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, Wolf H (1987) Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol 61: 570–578
Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ (1985) Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 313: 450–458
Nielsen C, Pedersen C, Lundgren JD, Gerstoft J (1993) Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 7: 1035–1040
Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362: 355–358
Psallidopoulos MC, Schnittman SM, Thompson LM III, Baseler M, Fauci AS, Lane HC, Salzman NP (1989) Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J Virol 63: 4626–4631
Sakai H, Kawamura M, Sakuragi J-I, Sakuragi S, Shibata R, Ishimoto A, Ono N, Ueda S, Adachi A (1993) Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J Virol 67: 1169–1174
Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede REY, van Steenwijk RP, Lange JMA, Schattenkerk JKME, Miedema F, Tersmette M (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 66: 1354–1360
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517
Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks W, Josephs SF, Gallo RC, Wong-Staal F (1986) Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45: 637–648
Stevenson M, Zhang X, Volsky DJ (1987) Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J Virol 61: 3741–3748
Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A (1988) Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell 53: 483–496
Tersmette M, de Goede REY, Al BJM, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F (1988) Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62: 2026–2032
Tersmette M, Gruters RA, de Wolf F, de Goede REY, Lange JMA, Schellekens PTA, Goudsmit J, Huisman HG, Miedema F (1989) Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 63: 2118–2125
Tersmette M, Lange JMA, de Goede REY, de Wolf F, Eeftink-Schattenkerk JKM, Schellekens PTA, Coutinho RA, Huisman JG, Goudsmit J, Miedema F (1989) Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i: 983–985
Yelle J, Berthiaume L (1982) Expression of virus-like particles in normal and transformed gerbil cells. Arch Virol 74: 77–83
Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213–222
Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, Gallo RC (1986) Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 231: 850–853
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yelle, J., Morisset, R. & Thibodeau, L. Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains. Archives of Virology 139, 155–172 (1994). https://doi.org/10.1007/BF01309461
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309461